ClinicalTrials.gg
Not yet recruitingNCT07466186Updated Mar 12, 2026

Resistance Training on Depression and Quality of Life in Type 1 Diabetic Women

An interventional study of Resistance exercises and Breathing exercises in Type 1 Diabetes Mellitus, sponsored by Middle East University. Not yet recruiting at 1 site in Egypt. Open to female participants aged 20 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Middle East University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
78
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 43 studies in Diabetes Mellitus, Type 1 with a site in Egypt — 7 open to participants now, 9 under way, 3 of them phase 3. Diabetes Mellitus, Type 1 · Egypt.

Planned enrollment
9th of 32
78 · median 60
Started
2026
with 4 others
No phase
17 of 43
1 open now
Registered
36th of 43
by date

Among the 43 studies in Diabetes Mellitus, Type 1 with a site in Egypt, this one is the 9th largest by planned enrollment of the 32 interventional ones that give a count, is one of 5 that started in 2026, is one of 17 with no phase, and was the 36th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

7 of the 43 studies in Diabetes Mellitus, Type 1 with a site in Egypt are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 20 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 43 studies in Diabetes Mellitus, Type 1 with a site in Egypt, or all of them as a file.
02

Study summary

Find out the effects of resistance training on depression, sleep quality, and quality of life in women with type 1 diabetes mellitus

Read the detailed description

Seventy-eight women aged 20 to 45 years with type 1 diabetes mellitus will be randomly assigned to either a resistance training group, which will receive both resistance and breathing exercises, or an active control group, which will receive breathing exercises only. The intervention will last for 12 weeks, with resistance exercises will be performed at moderate intensity. Outcomes will be assessed using the Beck Depression Inventory-II, the Pittsburgh Sleep Quality Index, and the Diabetes Quality of Life Questionnaire.

03

Conditions studied

  • Type 1 Diabetes Mellitus
04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of type 1 diabetes for more than 5 years
  2. Unchanged insulin doses for no less than three months
  3. Good glycemic control, defined as levels below 7%
  4. Minimal to moderate depressive symptoms
  5. Sleep quality impairment

Exclusion criteria

Exclusion Criteria:

Presence of other types of diabetes, unstable cardiopulmonary conditions, recent neurological or musculoskeletal problems affecting exercise, pregnancy, status, and the use of sedatives or antidepressants.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
78 participants (estimated)

Study arms

  • Active comparator
    Resistance training group

    Other: Resistance exercises · Other: Breathing exercises

  • Active comparator
    Control group

    Other: Breathing exercises

Interventions

  • OtherResistance exercises

    The program will include seven exercises targeting major muscle groups: chest press, triceps extension, and shoulder front raise for the upper limbs; back extensions and abdominal crunches for the trunk; and leg press, leg curl, and calf raise for the lower limbs.

  • OtherBreathing exercises

    The procedure will be first demonstrated and explained to each woman prior to the first session. Starting from a crook-lying position, participants will be guided to inhale through the nose for a count of four, hold their breath for another four counts, exhale slowly through the mouth over four counts, and then pause for an additional four counts before repeating the cycle.

06

What researchers measure

Primary outcomes

  1. Depression

    Depression will be assessed using the Beck Depression Inventory-II

    Time frame: Baseline and 12 weeks later

Secondary outcomes

  1. Sleep quality

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index

    Time frame: At baseline and 12 weeks later

  2. Quality of life

    The Arabic version of the Diabetes Quality of Life Questionnaire will be completed by each participant to assess quality of life

    Time frame: At baseline and after 12 weeks

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Jul 2026, 4 months later.

Of 852 non-industry interventional studies with no phase under Diabetes Mellitus, Type 1, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 4 months is below that.

Counting every sponsor, half of 957 studies reached it within 18 months; a quarter within 9 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2026
First posted
Mar 12, 2026
StartEst.
Mar 18, 2026
Primary completionEst.
Jul 21, 2026
CompletionEst.
Jul 28, 2026
Last update
Mar 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466186
Lead sponsor
Middle East University
Responsible party
Saher Lotfy El Gayar (Assistant Professor of Physical Therapy, Middle East University) — Principal investigator
First posted
Mar 12, 2026
Start date
Mar 18, 2026 (estimated)
Primary completion
Jul 21, 2026 (estimated)
Completion
Jul 28, 2026 (estimated)
Last update
Mar 12, 2026

Study contacts

Saher Elgayar, Ph.D
Contact
saherlotfy020@gmail.com
+201020429911
Mohammed Elhamrawy, Ph.D
Contact
Mohamed Saif
study director · National institute for Gerontology

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion